Concepts (163)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anorexia Nervosa | 16 | 2023 | 1286 | 3.260 |
Why?
|
| Amenorrhea | 14 | 2021 | 485 | 3.070 |
Why?
|
| Bone Density | 33 | 2023 | 3468 | 2.510 |
Why?
|
| Bone and Bones | 14 | 2023 | 2575 | 2.180 |
Why?
|
| Athletes | 12 | 2019 | 1093 | 2.040 |
Why?
|
| Adipose Tissue | 9 | 2021 | 3279 | 1.740 |
Why?
|
| Bone Marrow | 7 | 2021 | 2948 | 1.700 |
Why?
|
| Gastrectomy | 16 | 2024 | 663 | 1.670 |
Why?
|
| Obesity, Morbid | 7 | 2024 | 1213 | 1.600 |
Why?
|
| Radius | 8 | 2023 | 422 | 1.390 |
Why?
|
| Absorptiometry, Photon | 22 | 2023 | 1725 | 1.380 |
Why?
|
| Estrogens | 5 | 2022 | 1566 | 1.230 |
Why?
|
| Gastric Bypass | 4 | 2024 | 812 | 1.190 |
Why?
|
| Obesity | 23 | 2024 | 12745 | 1.170 |
Why?
|
| Tibia | 10 | 2023 | 1077 | 1.130 |
Why?
|
| Fractures, Bone | 5 | 2023 | 1947 | 0.940 |
Why?
|
| Estrogen Replacement Therapy | 6 | 2021 | 1203 | 0.900 |
Why?
|
| Oligomenorrhea | 2 | 2019 | 45 | 0.830 |
Why?
|
| Finite Element Analysis | 4 | 2019 | 431 | 0.830 |
Why?
|
| Young Adult | 47 | 2024 | 56430 | 0.810 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2023 | 251 | 0.770 |
Why?
|
| Estradiol | 5 | 2022 | 2020 | 0.750 |
Why?
|
| Adolescent | 51 | 2024 | 85781 | 0.730 |
Why?
|
| Bone Remodeling | 3 | 2022 | 575 | 0.710 |
Why?
|
| Adipose Tissue, Brown | 2 | 2016 | 757 | 0.670 |
Why?
|
| Anti-Obesity Agents | 2 | 2021 | 217 | 0.670 |
Why?
|
| Weight Loss | 5 | 2023 | 2622 | 0.650 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2021 | 2015 | 0.590 |
Why?
|
| Bariatric Surgery | 3 | 2023 | 952 | 0.580 |
Why?
|
| Eating | 1 | 2023 | 1536 | 0.550 |
Why?
|
| Bone Resorption | 1 | 2019 | 723 | 0.510 |
Why?
|
| Spine | 6 | 2023 | 1144 | 0.460 |
Why?
|
| Body Composition | 7 | 2023 | 2401 | 0.450 |
Why?
|
| Dyslipidemias | 1 | 2020 | 849 | 0.430 |
Why?
|
| Estrone | 2 | 2023 | 240 | 0.410 |
Why?
|
| Feeding Behavior | 3 | 2023 | 3188 | 0.400 |
Why?
|
| Appetite | 2 | 2023 | 243 | 0.380 |
Why?
|
| Pituitary-Adrenal System | 1 | 2014 | 553 | 0.370 |
Why?
|
| Fibronectins | 1 | 2014 | 726 | 0.370 |
Why?
|
| Sports | 1 | 2016 | 688 | 0.350 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.350 |
Why?
|
| Insulin Resistance | 1 | 2023 | 3864 | 0.350 |
Why?
|
| Weight-Bearing | 4 | 2019 | 515 | 0.320 |
Why?
|
| Lumbar Vertebrae | 6 | 2023 | 1848 | 0.310 |
Why?
|
| Hypogonadism | 1 | 2014 | 799 | 0.300 |
Why?
|
| Adult | 29 | 2024 | 214055 | 0.290 |
Why?
|
| Humans | 60 | 2024 | 744343 | 0.280 |
Why?
|
| Female | 44 | 2024 | 380194 | 0.280 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.280 |
Why?
|
| Body Weight | 3 | 2023 | 4669 | 0.240 |
Why?
|
| Menstruation | 2 | 2017 | 302 | 0.240 |
Why?
|
| Gonadal Hormones | 1 | 2023 | 29 | 0.230 |
Why?
|
| Peptide YY | 1 | 2022 | 130 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2023 | 20129 | 0.200 |
Why?
|
| Leucine | 1 | 2023 | 561 | 0.200 |
Why?
|
| Administration, Cutaneous | 2 | 2021 | 711 | 0.200 |
Why?
|
| Wrist Injuries | 1 | 2023 | 208 | 0.190 |
Why?
|
| Ghrelin | 1 | 2022 | 266 | 0.190 |
Why?
|
| Hypertension | 1 | 2020 | 8480 | 0.180 |
Why?
|
| Diaphyses | 1 | 2019 | 65 | 0.180 |
Why?
|
| Oxytocin | 1 | 2023 | 394 | 0.170 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 153 | 0.170 |
Why?
|
| Caloric Restriction | 1 | 2021 | 302 | 0.170 |
Why?
|
| Child | 12 | 2023 | 77709 | 0.160 |
Why?
|
| Independent Living | 1 | 2021 | 568 | 0.150 |
Why?
|
| Thinness | 2 | 2017 | 480 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11725 | 0.140 |
Why?
|
| Premenopause | 1 | 2019 | 1033 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2022 | 773 | 0.130 |
Why?
|
| Pseudohypoparathyroidism | 1 | 2015 | 87 | 0.130 |
Why?
|
| Basal Metabolism | 1 | 2016 | 168 | 0.130 |
Why?
|
| Chromogranins | 1 | 2015 | 160 | 0.130 |
Why?
|
| Verbal Learning | 1 | 2017 | 467 | 0.120 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 13989 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 199 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35421 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 418 | 0.110 |
Why?
|
| Testosterone | 1 | 2023 | 2420 | 0.110 |
Why?
|
| Exercise | 2 | 2021 | 5615 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2014 | 592 | 0.100 |
Why?
|
| Water | 1 | 2018 | 1395 | 0.100 |
Why?
|
| Male | 14 | 2023 | 350118 | 0.100 |
Why?
|
| Glucose | 1 | 2023 | 4397 | 0.100 |
Why?
|
| Self Report | 1 | 2022 | 3558 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6489 | 0.100 |
Why?
|
| Mental Recall | 1 | 2017 | 1205 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39050 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2017 | 25043 | 0.090 |
Why?
|
| Attitude | 1 | 2015 | 776 | 0.090 |
Why?
|
| Anthropometry | 1 | 2014 | 1350 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2015 | 696 | 0.080 |
Why?
|
| Insulin | 1 | 2023 | 6580 | 0.080 |
Why?
|
| Human Growth Hormone | 1 | 2014 | 683 | 0.080 |
Why?
|
| Executive Function | 1 | 2017 | 1364 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 879 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1807 | 0.080 |
Why?
|
| Endocrinology | 1 | 2014 | 443 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12026 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2024 | 77449 | 0.060 |
Why?
|
| Women's Health | 1 | 2014 | 2034 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3147 | 0.060 |
Why?
|
| Alleles | 1 | 2015 | 6933 | 0.060 |
Why?
|
| Base Sequence | 1 | 2015 | 12797 | 0.060 |
Why?
|
| Femur | 2 | 2020 | 1297 | 0.060 |
Why?
|
| Alabama | 1 | 2023 | 98 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2019 | 21746 | 0.060 |
Why?
|
| Emotions | 1 | 2015 | 2661 | 0.060 |
Why?
|
| Child Behavior | 1 | 2008 | 839 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2014 | 2899 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29063 | 0.050 |
Why?
|
| Administration, Oral | 2 | 2018 | 3913 | 0.040 |
Why?
|
| Desogestrel | 1 | 2018 | 23 | 0.040 |
Why?
|
| Models, Biological | 1 | 2015 | 9583 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2014 | 8554 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2023 | 53288 | 0.040 |
Why?
|
| Transdermal Patch | 1 | 2018 | 51 | 0.040 |
Why?
|
| Ethinyl Estradiol | 1 | 2018 | 116 | 0.040 |
Why?
|
| Femur Neck | 1 | 2019 | 309 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19905 | 0.040 |
Why?
|
| Risk Factors | 3 | 2021 | 72290 | 0.040 |
Why?
|
| Syntaxin 16 | 1 | 2015 | 12 | 0.030 |
Why?
|
| Middle Aged | 6 | 2021 | 213383 | 0.030 |
Why?
|
| Drive | 1 | 2015 | 35 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 185 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 63114 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1997 | 657 | 0.030 |
Why?
|
| Body Mass Index | 3 | 2019 | 12720 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 592 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2916 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 6622 | 0.030 |
Why?
|
| Age Distribution | 2 | 2013 | 2902 | 0.020 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1997 | 810 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 2437 | 0.020 |
Why?
|
| Anxiety | 1 | 2024 | 4297 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 163280 | 0.020 |
Why?
|
| Motor Activity | 2 | 2008 | 2714 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2015 | 1826 | 0.020 |
Why?
|
| Life Style | 2 | 2008 | 3835 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6196 | 0.020 |
Why?
|
| Vitamin D | 1 | 2019 | 3223 | 0.020 |
Why?
|
| Quality Control | 1 | 2008 | 841 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4931 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 6993 | 0.010 |
Why?
|
| Peptides | 1 | 2015 | 4409 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2459 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 3647 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5097 | 0.010 |
Why?
|
| Overweight | 1 | 2013 | 2371 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 9959 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2015 | 4286 | 0.010 |
Why?
|
| United States | 2 | 2023 | 69872 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12245 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
| Data Collection | 1 | 2008 | 3341 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2013 | 41006 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 5987 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1997 | 2297 | 0.010 |
Why?
|
| Survival Rate | 1 | 1997 | 12788 | 0.000 |
Why?
|
| Incidence | 1 | 1997 | 20947 | 0.000 |
Why?
|
Concepts
(163)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_